معرفی
Dr. Daniel Felmlee is a researcher at Newcastle University, focusing on Hepatitis C virus (HCV) and its interactions with lipid metabolism. His work explores genotype-specific differences in cholesterol pathways, lipoviral particles, and metabolic comorbidities in HCV patients, often in collaboration with colleagues like Dr. David Sheridan and Professor Margaret Bassendine.
- Key research areas: HCV virology, lipid metabolism, apolipoprotein regulation, insulin resistance, and atherosclerosis.
- Recent publications highlight HCV's manipulation of lipid pathways, including genotype 3's impact on cholesterol homeostasis (2022) and vascular compartment HCV dynamics (2017).
His studies frequently utilize lipidomics and clinical trials to investigate interventions like omega-3 fatty acids and fluvastatin for HCV therapy non-responders. Collaborations span virology, biochemistry, and clinical medicine, emphasizing the intersection of viral infection and metabolic disorders.
۰مقاله منتشرشده
